Literature DB >> 23117126

Nicotine related brain activity: the influence of smoking history and blood nicotine levels, an exploratory study.

Rinah T Yamamoto1, Michael L Rohan, Nathalie Goletiani, David Olson, MacKenzie Peltier, Perry F Renshaw, Nancy K Mello.   

Abstract

OBJECTIVE: In this study, we sought to explore brain activity in nicotine-dependent men in response to acute intravenous nicotine using pharmacological magnetic resonance imaging (phMRI).
METHODS: phMRI was used to evaluate brain activity in response to 1.5 mg/70 kg intravenous nicotine or saline. The nicotine and saline were administered on different visits. The time courses of individual subjects' nicotine levels were used as regressors to assess neural activity relating to the infusions. The influence of smoking history and physiological measures on the response to nicotine were also investigated.
RESULTS: Greater lifetime exposure to cigarette smoking was significantly correlated with higher peak serum nicotine levels. PhMRI analysis of the differential response of nicotine compared to the saline condition showed distinctive activation patterns when analyzed with the (a) nicotine time course, (b) nicotine time course controlling for smoking history (pack years), and (c) pack years controlling for nicotine.
CONCLUSIONS: These results suggest that smoking exposure history influences serum nicotine levels and the brain's response to nicotine. Alterations in brain activity may be a result of vascular and neuro-adaptations involved in drug exposure and addiction.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117126      PMCID: PMC3582808          DOI: 10.1016/j.drugalcdep.2012.10.002

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  64 in total

Review 1.  fMRI: a new tool for the in vivo localization of drug actions in the brain.

Authors:  E A Stein
Journal:  J Anal Toxicol       Date:  2001 Jul-Aug       Impact factor: 3.367

2.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Intermittent adaptation. A theory of drug tolerance, dependence and addiction.

Authors:  A Peper
Journal:  Pharmacopsychiatry       Date:  2009-05-11       Impact factor: 5.788

5.  Bayesian analysis of neuroimaging data in FSL.

Authors:  Mark W Woolrich; Saad Jbabdi; Brian Patenaude; Michael Chappell; Salima Makni; Timothy Behrens; Christian Beckmann; Mark Jenkinson; Stephen M Smith
Journal:  Neuroimage       Date:  2008-11-13       Impact factor: 6.556

6.  Robust group analysis using outlier inference.

Authors:  Mark Woolrich
Journal:  Neuroimage       Date:  2008-03-06       Impact factor: 6.556

7.  The rate hypothesis and agonist substitution approaches to cocaine abuse treatment.

Authors:  D A Gorelick
Journal:  Adv Pharmacol       Date:  1998

Review 8.  Neuronal nicotinic receptors: from structure to pathology.

Authors:  C Gotti; F Clementi
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

9.  Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch.

Authors:  Hwi-yeol Yun; Jeong-won Seo; Ji-eun Choi; In-hwan Baek; Wonku Kang; Kwang-il Kwon
Journal:  Biopharm Drug Dispos       Date:  2008-12       Impact factor: 1.627

10.  Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers.

Authors:  N L Benowitz; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1993-03       Impact factor: 6.875

View more
  5 in total

1.  Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior.

Authors:  Yantao Zuo; Alexey G Mukhin; Sudha Garg; Rachid Nazih; Frederique M Behm; Pradeep K Garg; Jed E Rose
Journal:  Neuropsychopharmacology       Date:  2014-09-30       Impact factor: 7.853

2.  Automatized smoking-related action schemata are reflected by reduced fMRI activity in sensorimotor brain regions of smokers.

Authors:  Ayse Ilkay Isik; Marcus J Naumer; Jochen Kaiser; Christian Buschenlange; Sandro Wiesmann; Stefan Czoschke; Yavor Yalachkov
Journal:  Neuroimage Clin       Date:  2017-06-17       Impact factor: 4.881

3.  Nicotine levels after IV nicotine and cigarette smoking in men.

Authors:  Nancy K Mello; Mackenzie R Peltier; Haley Duncanson
Journal:  Exp Clin Psychopharmacol       Date:  2013-05-06       Impact factor: 3.492

Review 4.  Laterality of Brain Activation for Risk Factors of Addiction.

Authors:  Harold W Gordon
Journal:  Curr Drug Abuse Rev       Date:  2016

5.  Investigating the neural correlates of smoking: Feasibility and results of combining electronic cigarettes with fMRI.

Authors:  Matthew B Wall; Alexander Mentink; Georgina Lyons; Oliwia S Kowalczyk; Lysia Demetriou; Rexford D Newbould
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.